Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021
Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Source: Eur Respir J 2010; 35: 496-504 Year: 2010
Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019
Role of biomarkers for early detection of lung cancer and chemoprevention Source: Eur Respir J 2002; 19: 1151-1158 Year: 2002
PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery Source: Eur Respir Rev 2013; 22: 148-152 Year: 2013
Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon Source: Eur Respir J 2012; 39: 669-676 Year: 2012
Impact of genetic factors on lung development in health and disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=93 Year: 2006
Stratified medicine: drugs meet genetics Source: Eur Respir Rev 2013; 22: 53-57 Year: 2013
Interstitial lung disease: new challenges and evolving phenotypes Source: Eur Respir Rev 2009; 19: 91-93 Year: 2010
New approaches to the understanding of complex chronic lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=345 Year: 2006
Multidisciplinary evaluation of interstitial lung diseases: current insights Source: Eur Respir Rev, 26 (144) 170002; 10.1183/16000617.0002-2017 Year: 2017
Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012
Application of ’omics technologies to biomarker discovery in inflammatory lung diseases Source: Eur Respir J 2013; 42: 802-825 Year: 2013
Biomarkers for fibrotic lung disease - new clinical benchmarks from the lab? Source: Annual Congress 2013 –ME3 Biomarkers for fibrotic lung disease – new clinical benchmarks from the lab? Year: 2013
Clusters, classification and epidemiology of interstitial lung diseases: concepts, methods and critical reflections Source: Eur Respir J 2001; 18: 101S-106S Year: 2001
Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-a-chip Source: International Congress 2015 – New models for treating airway diseases Year: 2015
Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019
Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=27 Year: 2005
Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases) Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016